References -
1. Miya R, Malpani AK, Keri S, Panagaon R. Drug Induced Steven- Johnson Syndrome
(SJS). IJOPP. 2019 Jun 1;12(2):133–5.
2. Valeyrie-Allanore L, Roujeau J-C. Chapter 40. Epidermal Necrolysis (Stevens–Johnson
Syndrome and Toxic Epidermal Necrolysis). In: Goldsmith LA, Katz SI, Gilchrest BA,
Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine
[Internet]. 8th ed .
3. Bhat M, Kakunje A, Mithur R, Shenoy MM, Mashood KA, Puthran S, et al. Stevens-
Johnson Syndrome while on lamotrigine and NSAID:A case report. Kerala Journal of
Psychiatry. 2021; 34(1), 64–7.
4. Sassolas B, Haddad C, Mockenhaupt M, Dunandt A, Liss Y, Bork K, et al. ALDEN, an
algorithm for assessment of drug causality in Stevens–Johnson Syndrome and toxic
epider- mal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther
2010;88:60.
5. Hirschfeld RMA, Kasper S. A review of the evidence for carbamazepine and
oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol. 2004
;7(4):507–22.
6. Trivedi BS, Darji NH, Malhotra SD, Patel PR. Antiepileptic Drugs-induced Stevens–
Johnson syndrome: A case Series. J Basic Clin Pharm. 2016;8(1):42–4.
7. Dogan EA, Usta BE, Bilgen R, Senol Y, Aktekin B. Efficacy, tolerability, and side
effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients
with newly diagnosed partial epilepsy. Epilepsy Behav. 2008;13(1):156-161.
8. Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are
distinctly different antiepileptic drugs? Epilepsy Behav 2004;5(5):627–35.
9. Wei C-Y, Chung W-H, Huang H-W, Chen Y-T, Hung S-I. Direct interaction between
HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
J Allergy Clin Immunol 2012;129(6):1562-1569.e5.
10. Franciotta D, Kwan P, Perucca E. Genetic basis for idiosyncratic reactions to
antiepileptic drugs. Curr Opin Neurol 2009;22(2):144–9.